drugset / Trial / NCT01042730

Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)

NCT01042730

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the prevention of cardiovascular disease by moderate cholesterol lowering therapy, pitavastatin 1mg/day or aggressive cholesterol lowering therapy, pitavastatin 4mg/day in patients with stable coronary artery disease.

Timeline

Start
2010-02
Primary completion
2016-06
Completion
2017-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pitavastatin Small molecule 1 mg
Comparator Pitavastatin Small molecule 4 mg